CD44 and Miyoshi myopathy: Moderate/strong CD44 expression was also more prevalent in SOP or MM-EMD/pEMP paraskeletal (82%) compared to MM-EMD/pEMP not paraskeletal (44%) or classical medullary/osseous MM (33%) (p = 0.02, Figure 2B).